{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:25:35Z","timestamp":1785522335381,"version":"3.56.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Central serous chorioretinopathy (CSC) represents a significant cause of visual impairment, particularly in working-age individuals. Despite advances in multimodal imaging and evidence supporting photodynamic therapy (PDT) as the mainstay of chronic CSC, current clinical workflows are still affected by variability in image interpretation, manual quantification, and individualized treatment selection. This narrative review investigates the utility of Artificial Intelligence (AI) in improving the diagnosis, prognosis, and management of CSC. AI-based image analysis, including Optical Coherence Tomography (OCT), Optical Coherence Tomography Angiography (OCTA), and Fundus Fluorescein Angiography (FFA), has demonstrated high diagnostic accuracy across selected datasets and the ability to identify relevant biomarkers, thereby improving efficiency and consistency. Machine learning models demonstrate promising predictive power for subretinal fluid absorption, visual acuity outcomes, and disease recurrence, and identify critical prognostic factors. While emerging, AI-guided treatment strategies hold promise for personalized therapy, particularly for optimizing PDT, laser-based interventions, and follow-up strategies. The integration of AI into clinical decision-making workflows may elevate diagnostic capabilities, especially for non-specialists, and reduce clinical workload. However, the widespread implementation of AI in CSC faces notable challenges, including dataset bias, limited external validation, insufficient representation of differential diagnoses, regulatory complexities, and ethical considerations pertaining to transparency and equitable access. Future directions emphasize integrating multimodal data, fostering global collaborative efforts, and developing robust, generalizable AI models to fully realize AI\u2019s potential to enhance patient care and optimize healthcare delivery for CSC.<\/jats:p>","DOI":"10.1186\/s40942-026-00867-6","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:14:28Z","timestamp":1779956068000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Utility of artificial intelligence for the diagnosis, prognosis, and management of central serous chorioretinopathy: a narrative review"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8745-3464","authenticated-orcid":false,"given":"Jos\u00e9 Ignacio","family":"Fern\u00e1ndez-Vigo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Valverde-Meg\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara","family":"Burgos-Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Joaquim","family":"de Moura Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Ly-Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"867_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","volume":"48","author":"A Daruich","year":"2015","unstructured":"Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, et al. Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res. 2015;48:82\u2013118. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.05.003.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"867_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","volume":"86","author":"M Wang","year":"2008","unstructured":"Wang M, Munch IC, Hasler PW, Pr\u00fcnte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol. 2008;86(2):126\u201345. https:\/\/doi.org\/10.1111\/j.1600-0420.2007.00889.x.","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"867_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ophtha.2024.09.003","volume":"132","author":"LA Kim","year":"2025","unstructured":"Kim LA, Maguire MG, Weng CY, Meyerle CB, Freund KB. Therapies for central serous chorioretinopathy: a report by the American Academy of Ophthalmology. Ophthalmology. 2025;132(3):343\u201353. https:\/\/doi.org\/10.1016\/j.ophtha.2024.09.003.","journal-title":"Ophthalmology"},{"issue":"3","key":"867_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/ceo.14202","volume":"51","author":"AT Fung","year":"2023","unstructured":"Fung AT, Yang Y, Kam AW. Central serous chorioretinopathy: a review. Clin Exp Ophthalmol. 2023;51(3):243\u201370. https:\/\/doi.org\/10.1111\/ceo.14202.","journal-title":"Clin Exp Ophthalmol"},{"issue":"12","key":"867_CR5","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1136\/bjophthalmol-2021-319403","volume":"106","author":"A Kido","year":"2022","unstructured":"Kido A, Miyake M, Tamura H, Hiragi S, Kimura T, Ogino K, et al. Incidence of central serous chorioretinopathy (2011\u20132018): a nationwide population-based cohort study of Japan. Br J Ophthalmol. 2022;106(12):1748\u201353. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319403.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"867_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1001\/jamaophthalmol.2023.0292","volume":"141","author":"JT R\u00e4m\u00f6","year":"2023","unstructured":"R\u00e4m\u00f6 JT, Abner E, van Dijk EHC, Sanfilippo PG, Saw SM, Tham YC, et al. Overlap of genetic loci for central serous chorioretinopathy with age-related macular degeneration. JAMA Ophthalmol. 2023;141(5):449\u201357. https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.0292.","journal-title":"JAMA Ophthalmol"},{"key":"867_CR7","doi-asserted-by":"publisher","first-page":"100973","DOI":"10.1016\/j.preteyeres.2021.100973","volume":"86","author":"RF Spaide","year":"2022","unstructured":"Spaide RF, Cheung CMG, Matsumoto H, Kishi S, Boon CJF, van Dijk EHC, et al. Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders. Prog Retin Eye Res. 2022;86:100973. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100973.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"867_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","volume":"58","author":"B Nicholson","year":"2013","unstructured":"Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. 2013;58(2):103\u201326. https:\/\/doi.org\/10.1016\/j.survophthal.2012.07.004.","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"867_CR9","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","volume":"29","author":"Y Imamura","year":"2009","unstructured":"Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009;29(10):1469\u201373. https:\/\/doi.org\/10.1097\/IAE.0b013e3181be0a83.","journal-title":"Retina"},{"issue":"1","key":"867_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","volume":"33","author":"CMG Cheung","year":"2019","unstructured":"Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB. Pachychoroid disease. Eye (Lond). 2019;33(1):14\u201333. https:\/\/doi.org\/10.1038\/s41433-018-0158-4.","journal-title":"Eye (Lond)"},{"issue":"8","key":"867_CR11","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1167\/iovs.05-1246","volume":"47","author":"HK Tewari","year":"2006","unstructured":"Tewari HK, Gadia R, Kumar D, Venkatesh P, Garg SP. Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study. Invest Ophthalmol Vis Sci. 2006;47(8):3474\u20138. https:\/\/doi.org\/10.1167\/iovs.05-1246.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"867_CR12","first-page":"799","volume":"84","author":"LA Yannuzzi","year":"1986","unstructured":"Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc. 1986;84:799\u2013845.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"2","key":"867_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","volume":"41","author":"G Liew","year":"2013","unstructured":"Liew G, Quin G, Gillies M, Fraser-Bell S. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exp Ophthalmol. 2013;41(2):201\u201314. https:\/\/doi.org\/10.1111\/j.1442-9071.2012.02848.x.","journal-title":"Clin Exp Ophthalmol"},{"key":"867_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/OPTH.S115685","volume":"11","author":"MB Breukink","year":"2017","unstructured":"Breukink MB, Dingemans AJ, den Hollander AI, Keunen JEE, MacLaren RE, Querques G, et al. Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life. Clin Ophthalmol. 2017;11:39\u201346. https:\/\/doi.org\/10.2147\/OPTH.S115685.","journal-title":"Clin Ophthalmol"},{"key":"867_CR15","doi-asserted-by":"publisher","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","volume":"73","author":"TJ van Rijssen","year":"2019","unstructured":"van Rijssen TJ, van Dijk EHC, Yzer S, Ohno-Matsui K, Keunen JEE, Schlingemann RO, et al. Central serous chorioretinopathy: towards an evidence-based treatment guideline. Prog Retin Eye Res. 2019;73:100770. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.07.003.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"867_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/IAE.0000000000001600","volume":"38","author":"E Bousquet","year":"2018","unstructured":"Bousquet E, Bonnin S, Mrejen S, Krivosic V, Tadayoni R, Gaudric A. Optical coherence tomography angiography of flat irregular pigment epithelium detachment in chronic central serous chorioretinopathy. Retina. 2018;38(3):629\u201338. https:\/\/doi.org\/10.1097\/IAE.0000000000001600.","journal-title":"Retina"},{"issue":"7","key":"867_CR17","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.4103\/ijo.IJO_1566_19","volume":"68","author":"S Garg","year":"2020","unstructured":"Garg S, Joshi S. Multimodal imaging in central serous chorioretinopathy. Indian J Ophthalmol. 2020;68(7):1315\u201324. https:\/\/doi.org\/10.4103\/ijo.IJO_1566_19.","journal-title":"Indian J Ophthalmol"},{"issue":"11","key":"867_CR18","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.oret.2020.06.021","volume":"4","author":"J Chhablani","year":"2020","unstructured":"Chhablani J, Cohen FB. Multimodal imaging-based central serous chorioretinopathy classification. Ophthalmol Retina. 2020;4(11):1043\u20136. https:\/\/doi.org\/10.1016\/j.oret.2020.06.021.","journal-title":"Ophthalmol Retina"},{"issue":"9","key":"867_CR19","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1097\/IAE.0000000000001040","volume":"36","author":"R Agrawal","year":"2016","unstructured":"Agrawal R, Chhablani J, Tan KA, Shah S, Sarvaiya C, Banker A. Choroidal vascularity index in central serous chorioretinopathy. Retina. 2016;36(9):1646\u201351. https:\/\/doi.org\/10.1097\/IAE.0000000000001040.","journal-title":"Retina"},{"issue":"1","key":"867_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/aos.14901","volume":"100","author":"Y Subhi","year":"2022","unstructured":"Subhi Y, Bjerager J, van Dijk EHC, S\u00f8rensen TL, Boon CJF, Kessel L. Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial data. Acta Ophthalmol. 2022;100(1):89\u201395. https:\/\/doi.org\/10.1111\/aos.14901.","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"867_CR21","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","volume":"125","author":"EHC van Dijk","year":"2018","unstructured":"van Dijk EHC, Fauser S, Breukink MB, Blanco-Garavito R, Groenewoud JMM, Keunen JEE, et al. Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE Trial. Ophthalmology. 2018;125(10):1547\u201355. https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.021.","journal-title":"Ophthalmology"},{"issue":"2","key":"867_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/bjophthalmol-2018-313173","volume":"103","author":"DSW Ting","year":"2019","unstructured":"Ting DSW, Pasquale LR, Peng L, Campbell JP, Lee AY, Raman R, et al. Artificial intelligence and deep learning in ophthalmology. Br J Ophthalmol. 2019;103(2):167\u201375. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313173.","journal-title":"Br J Ophthalmol"},{"issue":"22","key":"867_CR23","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2016.17216","volume":"316","author":"V Gulshan","year":"2016","unstructured":"Gulshan V, Peng L, Coram M, Stumpe MC, Wu D, Narayanaswamy A, et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA. 2016;316(22):2402\u201310. https:\/\/doi.org\/10.1001\/jama.2016.17216.","journal-title":"JAMA"},{"issue":"9","key":"867_CR24","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","volume":"24","author":"J De Fauw","year":"2018","unstructured":"De Fauw J, Ledsam JR, Romera-Paredes B, Nikolov S, Tomasev N, Blackwell S, et al. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat Med. 2018;24(9):1342\u201350. https:\/\/doi.org\/10.1038\/s41591-018-0107-6.","journal-title":"Nat Med"},{"issue":"11","key":"867_CR25","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/jamaophthalmol.2017.3782","volume":"135","author":"PM Burlina","year":"2017","unstructured":"Burlina PM, Joshi N, Pekala M, Pacheco KD, Freund DE, Bressler NM. Automated grading of age-related macular degeneration from color fundus images using deep convolutional neural networks. JAMA Ophthalmol. 2017;135(11):1170\u20136. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.3782.","journal-title":"JAMA Ophthalmol"},{"key":"867_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2018.07.004","volume":"67","author":"U Schmidt-Erfurth","year":"2018","unstructured":"Schmidt-Erfurth U, Sadeghipour A, Gerendas BS, Waldstein SM, Bogunovi\u0107 H. Artificial intelligence in retina. Prog Retin Eye Res. 2018;67:1\u201329. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.07.004.","journal-title":"Prog Retin Eye Res"},{"issue":"7553","key":"867_CR27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature14539","volume":"521","author":"Y LeCun","year":"2015","unstructured":"LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521(7553):436\u201344. https:\/\/doi.org\/10.1038\/nature14539.","journal-title":"Nature"},{"issue":"4","key":"867_CR28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.oret.2016.12.009","volume":"1","author":"CS Lee","year":"2017","unstructured":"Lee CS, Baughman DM, Lee AY. Deep learning is effective for classifying normal versus age-related macular degeneration OCT images. Ophthalmol Retina. 2017;1(4):322\u20137. https:\/\/doi.org\/10.1016\/j.oret.2016.12.009.","journal-title":"Ophthalmol Retina"},{"issue":"4","key":"867_CR29","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1109\/TMI.2017.2780115","volume":"37","author":"R Rasti","year":"2018","unstructured":"Rasti R, Rabbani H, Mehridehnavi A, Hajizadeh F. Macular OCT classification using a multi-scale convolutional neural network ensemble. IEEE Trans Med Imaging. 2018;37(4):1024\u201334. https:\/\/doi.org\/10.1109\/TMI.2017.2780115.","journal-title":"IEEE Trans Med Imaging"},{"key":"867_CR30","doi-asserted-by":"publisher","first-page":"m3164","DOI":"10.1136\/bmj.m3164","volume":"370","author":"X Liu","year":"2020","unstructured":"Liu X, Rivera SC, Moher D, Calvert MJ, Denniston AK, SPIRIT-AI, CONSORT-AI Working Group. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. BMJ. 2020;370:m3164. https:\/\/doi.org\/10.1136\/bmj.m3164.","journal-title":"BMJ"},{"issue":"6","key":"867_CR31","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41591-020-0941-1","volume":"26","author":"V Sounderajah","year":"2020","unstructured":"Sounderajah V, Ashrafian H, Aggarwal R, De Fauw J, Denniston AK, Greaves F, et al. Developing specific reporting guidelines for diagnostic accuracy studies assessing AI interventions: the STARD-AI Steering Group. Nat Med. 2020;26(6):807\u20138. https:\/\/doi.org\/10.1038\/s41591-020-0941-1.","journal-title":"Nat Med"},{"key":"867_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41746-018-0048-y","volume":"1","author":"PA Keane","year":"2018","unstructured":"Keane PA, Topol EJ. With an eye to AI and autonomous diagnosis. NPJ Digit Med. 2018;1:40. https:\/\/doi.org\/10.1038\/s41746-018-0048-y.","journal-title":"NPJ Digit Med"},{"key":"867_CR33","doi-asserted-by":"publisher","unstructured":"Beede E, Baylor E, Hersch F, Iurchenko A, Wilcox L, Ruamviboonsuk P, et al. A human-centered evaluation of a deep learning system deployed in clinics for the detection of diabetic retinopathy. Proceedings of the 2020 CHI Conference on Human Factors in Computing Systems. 2020:1\u201312. https:\/\/doi.org\/10.1145\/3313831.3376718.","DOI":"10.1145\/3313831.3376718"},{"issue":"1","key":"867_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12916-019-1426-2","volume":"17","author":"CJ Kelly","year":"2019","unstructured":"Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med. 2019;17(1):195. https:\/\/doi.org\/10.1186\/s12916-019-1426-2.","journal-title":"BMC Med"},{"issue":"11","key":"867_CR35","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMp1714229","volume":"378","author":"DS Char","year":"2018","unstructured":"Char DS, Shah NH, Magnus D. Implementing machine learning in health care - addressing ethical challenges. N Engl J Med. 2018;378(11):981\u20133. https:\/\/doi.org\/10.1056\/NEJMp1714229.","journal-title":"N Engl J Med"},{"issue":"6","key":"867_CR36","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.1016\/S2589-7500(22)00063-2","volume":"4","author":"JW Gichoya","year":"2022","unstructured":"Gichoya JW, Banerjee I, Bhimireddy AR, Burns JL, Celi LA, Chen LC, et al. AI recognition of patient race in medical imaging: a modelling study. Lancet Digit Health. 2022;4(6):e406\u201314. https:\/\/doi.org\/10.1016\/S2589-7500(22)00063-2.","journal-title":"Lancet Digit Health"},{"key":"867_CR37","unstructured":"US Food and Drug Administration. Artificial intelligence-enabled medical devices. https:\/\/www.fda.gov\/medical-devices\/software-medical-device-samd\/artificial-intelligence-enabled-medical-devices. Accessed 4 May 2026."},{"key":"867_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41746-020-00324-0","volume":"3","author":"S Benjamens","year":"2020","unstructured":"Benjamens S, Dhunnoo P, Mesk\u00f3 B. The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database. NPJ Digit Med. 2020;3:118. https:\/\/doi.org\/10.1038\/s41746-020-00324-0.","journal-title":"NPJ Digit Med"},{"issue":"1","key":"867_CR39","doi-asserted-by":"publisher","first-page":"18852","DOI":"10.1038\/s41598-020-75816-w","volume":"10","author":"J Yoon","year":"2020","unstructured":"Yoon J, Han J, Park JI, Hwang JS, Han JM, Sohn J, et al. Optical coherence tomography-based deep-learning model for detecting central serous chorioretinopathy. Sci Rep. 2020;10(1):18852. https:\/\/doi.org\/10.1038\/s41598-020-75816-w.","journal-title":"Sci Rep"},{"key":"867_CR40","doi-asserted-by":"publisher","first-page":"e48142","DOI":"10.2196\/48142","volume":"25","author":"J Yoon","year":"2023","unstructured":"Yoon J, Han J, Ko J, Choi S, Park JI, Hwang JS, et al. Developing and evaluating an AI-based computer-aided diagnosis system for retinal disease: diagnostic study for central serous chorioretinopathy. J Med Internet Res. 2023;25:e48142. https:\/\/doi.org\/10.2196\/48142.","journal-title":"J Med Internet Res"},{"issue":"1","key":"867_CR41","doi-asserted-by":"publisher","first-page":"9335","DOI":"10.1038\/s41598-022-13369-5","volume":"12","author":"D Jee","year":"2022","unstructured":"Jee D, Yoon JH, Ra H, Kwon JW, Baek J. Predicting persistent central serous chorioretinopathy using multiple optical coherence tomographic images by deep learning. Sci Rep. 2022;12(1):9335. https:\/\/doi.org\/10.1038\/s41598-022-13369-5.","journal-title":"Sci Rep"},{"issue":"5","key":"867_CR42","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1364\/BOE.8.002732","volume":"8","author":"L Fang","year":"2017","unstructured":"Fang L, Cunefare D, Wang C, Guymer RH, Li S, Farsiu S. Automatic segmentation of nine retinal layer boundaries in OCT images of non-exudative AMD patients using deep learning and graph search. Biomed Opt Express. 2017;8(5):2732\u201344. https:\/\/doi.org\/10.1364\/BOE.8.002732.","journal-title":"Biomed Opt Express"},{"issue":"8","key":"867_CR43","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1364\/BOE.8.003627","volume":"8","author":"AG Roy","year":"2017","unstructured":"Roy AG, Conjeti S, Karri SPK, Sheet D, Katouzian A, Wachinger C, et al. ReLayNet: retinal layer and fluid segmentation of macular optical coherence tomography using fully convolutional networks. Biomed Opt Express. 2017;8(8):3627\u201342. https:\/\/doi.org\/10.1364\/BOE.8.003627.","journal-title":"Biomed Opt Express"},{"key":"867_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40942-024-00560-6","volume":"10","author":"L Ferro Desideri","year":"2024","unstructured":"Ferro Desideri L, Anguita R, Berger LE, Scharf JM, Ng R, de Sisternes L, et al. Analysis of optical coherence tomography biomarker probability detection in central serous chorioretinopathy by using an artificial intelligence-based biomarker detector. Int J Retina Vitreous. 2024;10:42. https:\/\/doi.org\/10.1186\/s40942-024-00560-6.","journal-title":"Int J Retina Vitreous"},{"key":"867_CR45","doi-asserted-by":"publisher","first-page":"21090","DOI":"10.1038\/srep21090","volume":"6","author":"R Agrawal","year":"2016","unstructured":"Agrawal R, Gupta P, Tan KA, Cheung CM, Wong TY, Cheng CY. Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study. Sci Rep. 2016;6:21090. https:\/\/doi.org\/10.1038\/srep21090.","journal-title":"Sci Rep"},{"key":"867_CR46","doi-asserted-by":"publisher","first-page":"100972","DOI":"10.1016\/j.preteyeres.2021.100972","volume":"86","author":"U Schmidt-Erfurth","year":"2022","unstructured":"Schmidt-Erfurth U, Reiter GS, Riedl S, Sadeghipour A, Gerendas BS, Schlanitz FG, et al. AI-based monitoring of retinal fluid in disease activity and under therapy. Prog Retin Eye Res. 2022;86:100972. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100972.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"867_CR47","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/IAE.0000000000003965","volume":"44","author":"L Ferro Desideri","year":"2024","unstructured":"Ferro Desideri L, Anguita R, Berger LE, Scharf JM, Ng R, de Sisternes L, et al. Baseline spectral-domain optical coherence tomographic retinal layer features identified by artificial intelligence predict the course of central serous chorioretinopathy. Retina. 2024;44(2):316\u201323. https:\/\/doi.org\/10.1097\/IAE.0000000000003965.","journal-title":"Retina"},{"key":"867_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ajo.2026.02.022","volume":"286","author":"P Forte","year":"2026","unstructured":"Forte P, Cattaneo J, Huang SC, Corazza P, Magnin S, Mangoni L, et al. Outer retinal erosion and outer retinal pinching at the origin of subretinal fluid in central serous chorioretinopathy. Am J Ophthalmol. 2026;286:12\u201328. https:\/\/doi.org\/10.1016\/j.ajo.2026.02.022.","journal-title":"Am J Ophthalmol"},{"key":"867_CR49","doi-asserted-by":"publisher","first-page":"7148245","DOI":"10.1155\/2017\/7148245","volume":"2017","author":"S Khalid","year":"2017","unstructured":"Khalid S, Akram MU, Hassan T, Nasim A, Jameel A. Fully automated robust system to detect retinal edema, central serous chorioretinopathy, and age-related macular degeneration from optical coherence tomography images. Biomed Res Int. 2017;2017:7148245. https:\/\/doi.org\/10.1155\/2017\/7148245.","journal-title":"Biomed Res Int"},{"issue":"1","key":"867_CR50","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41598-021-04424-z","volume":"12","author":"J Yoon","year":"2022","unstructured":"Yoon J, Han J, Ko J, Choi S, Park JI, Hwang JS, et al. Classifying central serous chorioretinopathy subtypes with a deep neural network using optical coherence tomography images: a cross-sectional study. Sci Rep. 2022;12(1):422. https:\/\/doi.org\/10.1038\/s41598-021-04424-z.","journal-title":"Sci Rep"},{"issue":"3","key":"867_CR51","doi-asserted-by":"publisher","first-page":"242","DOI":"10.21037\/atm-20-1519","volume":"9","author":"F Xu","year":"2021","unstructured":"Xu F, Xiang Y, Wan C, You Q, Zhou L, Li C, et al. Predicting subretinal fluid absorption with machine learning in patients with central serous chorioretinopathy. Ann Transl Med. 2021;9(3):242. https:\/\/doi.org\/10.21037\/atm-20-1519.","journal-title":"Ann Transl Med"},{"key":"867_CR52","doi-asserted-by":"publisher","first-page":"103107","DOI":"10.1016\/j.pdpdt.2022.103107","volume":"40","author":"JI Fern\u00e1ndez-Vigo","year":"2022","unstructured":"Fern\u00e1ndez-Vigo JI, G\u00f3mez Calleja V, de Moura Ramos JJ, Novo-Bujan J, Burgos-Blasco B, L\u00f3pez-Guajardo L, et al. Prediction of the response to photodynamic therapy in patients with chronic central serous chorioretinopathy based on optical coherence tomography using deep learning. Photodiagnosis Photodyn Ther. 2022;40:103107. https:\/\/doi.org\/10.1016\/j.pdpdt.2022.103107.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"867_CR53","doi-asserted-by":"publisher","first-page":"649221","DOI":"10.3389\/fbioe.2021.649221","volume":"9","author":"F Xu","year":"2021","unstructured":"Xu F, Wan C, Zhao L, Liu S, Hong J, Xiang Y, et al. Predicting post-therapeutic visual acuity and OCT images in patients with central serous chorioretinopathy by artificial intelligence. Front Bioeng Biotechnol. 2021;9:649221. https:\/\/doi.org\/10.3389\/fbioe.2021.649221.","journal-title":"Front Bioeng Biotechnol"},{"issue":"4","key":"867_CR54","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","volume":"126","author":"S Mrejen","year":"2019","unstructured":"Mrejen S, Balaratnasingam C, Kaden TR, Yu S, Moore NA, Sheth S, et al. Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy. Ophthalmology. 2019;126(4):576\u201388. https:\/\/doi.org\/10.1016\/j.ophtha.2018.12.048.","journal-title":"Ophthalmology"},{"issue":"10","key":"867_CR55","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","volume":"115","author":"WM Chan","year":"2008","unstructured":"Chan WM, Lai TY, Lai RY, Liu DT, Lam DS. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology. 2008;115(10):1756\u201365. https:\/\/doi.org\/10.1016\/j.ophtha.2008.04.014.","journal-title":"Ophthalmology"},{"issue":"1","key":"867_CR56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/IAE.0b013e3181e378f2","volume":"31","author":"JY Shin","year":"2011","unstructured":"Shin JY, Woo SJ, Yu HG, Park KH. Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy. Retina. 2011;31(1):119\u201326. https:\/\/doi.org\/10.1097\/IAE.0b013e3181e378f2.","journal-title":"Retina"},{"issue":"2","key":"867_CR57","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.survophthal.2025.07.011","volume":"71","author":"H Nouri","year":"2026","unstructured":"Nouri H, Hasan N, Abtahi SH, Ahmadieh H, Chhablani J. Deep learning in central serous chorioretinopathy. Surv Ophthalmol. 2026;71(2):718\u201348. https:\/\/doi.org\/10.1016\/j.survophthal.2025.07.011.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"867_CR58","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1038\/s41598-022-05051-y","volume":"12","author":"J Ko","year":"2022","unstructured":"Ko J, Han J, Yoon J, Park JI, Hwang JS, Han JM, et al. Assessing central serous chorioretinopathy with deep learning and multiple optical coherence tomography images. Sci Rep. 2022;12(1):1831. https:\/\/doi.org\/10.1038\/s41598-022-05051-y.","journal-title":"Sci Rep"},{"issue":"4","key":"867_CR59","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/IAE.0000000000002457","volume":"40","author":"KS Asano","year":"2020","unstructured":"Asano KS, Asaoka R, Asano S, Murata H, Kawakami R, Kanamoto T, et al. Elongated photoreceptor outer segment length and prognosis of chronic central serous chorioretinopathy. Retina. 2020;40(4):750\u20137. https:\/\/doi.org\/10.1097\/IAE.0000000000002457.","journal-title":"Retina"},{"issue":"6","key":"867_CR60","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/IAE.0000000000002110","volume":"39","author":"J Yu","year":"2019","unstructured":"Yu J, Jiang C, Xu G. Correlations between changes in photoreceptor layer and other clinical characteristics in central serous chorioretinopathy. Retina. 2019;39(6):1110\u20136. https:\/\/doi.org\/10.1097\/IAE.0000000000002110.","journal-title":"Retina"},{"issue":"1","key":"867_CR61","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ajo.2004.08.037","volume":"139","author":"FC Piccolino","year":"2005","unstructured":"Piccolino FC, de la Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A, et al. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol. 2005;139(1):87\u201399. https:\/\/doi.org\/10.1016\/j.ajo.2004.08.037.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"867_CR62","doi-asserted-by":"publisher","first-page":"20446","DOI":"10.1038\/s41598-021-99648-w","volume":"11","author":"M Pfau","year":"2021","unstructured":"Pfau M, van Dijk EHC, van Rijssen TJ, Schmitz-Valckenberg S, Holz FG, Fleckenstein M, et al. Estimation of current and post-treatment retinal function in chronic central serous chorioretinopathy using artificial intelligence. Sci Rep. 2021;11(1):20446. https:\/\/doi.org\/10.1038\/s41598-021-99648-w.","journal-title":"Sci Rep"},{"issue":"5","key":"867_CR63","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.3390\/jcm12052069","volume":"12","author":"S Caplash","year":"2023","unstructured":"Caplash S, Surakiatchanukul T, Arora S, Lupidi M, Chhablani J. Multimodal imaging based predictors for the development of choroidal neovascularization in patients with central serous chorioretinopathy. J Clin Med. 2023;12(5):2069. https:\/\/doi.org\/10.3390\/jcm12052069.","journal-title":"J Clin Med"},{"issue":"1","key":"867_CR64","doi-asserted-by":"publisher","first-page":"32250","DOI":"10.1038\/s41598-025-17499-9","volume":"15","author":"M Kitano","year":"2025","unstructured":"Kitano M, Aoki S, Kitamoto K, Terao R, Inoue T, Obata R, et al. Predictive factors for the development of macular neovascularization in chronic central serous chorioretinopathy. Sci Rep. 2025;15(1):32250. https:\/\/doi.org\/10.1038\/s41598-025-17499-9.","journal-title":"Sci Rep"},{"issue":"4","key":"867_CR65","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41591-021-01312-x","volume":"27","author":"E Wu","year":"2021","unstructured":"Wu E, Wu K, Daneshjou R, Ouyang D, Ho DE, Zou J. How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals. Nat Med. 2021;27(4):582\u20134. https:\/\/doi.org\/10.1038\/s41591-021-01312-x.","journal-title":"Nat Med"},{"issue":"5","key":"867_CR66","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/s41591-022-01772-9","volume":"28","author":"B Vasey","year":"2022","unstructured":"Vasey B, Nagendran M, Campbell B, Clifton DA, Collins GS, Denaxas S, et al. Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI. Nat Med. 2022;28(5):924\u201333. https:\/\/doi.org\/10.1038\/s41591-022-01772-9.","journal-title":"Nat Med"},{"issue":"4","key":"867_CR67","doi-asserted-by":"publisher","first-page":"e1312","DOI":"10.1002\/widm.1312","volume":"9","author":"A Holzinger","year":"2019","unstructured":"Holzinger A, Langs G, Denk H, Zatloukal K, Muller H. Causability and explainability of artificial intelligence in medicine. Wiley Interdiscip Rev Data Min Knowl Discov. 2019;9(4):e1312. https:\/\/doi.org\/10.1002\/widm.1312.","journal-title":"Wiley Interdiscip Rev Data Min Knowl Discov"},{"issue":"6464","key":"867_CR68","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1126\/science.aax2342","volume":"366","author":"Z Obermeyer","year":"2019","unstructured":"Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366(6464):447\u201353. https:\/\/doi.org\/10.1126\/science.aax2342.","journal-title":"Science"},{"issue":"6","key":"867_CR69","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s10384-021-00870-4","volume":"65","author":"JI Fern\u00e1ndez-Vigo","year":"2021","unstructured":"Fern\u00e1ndez-Vigo JI, Moreno-Morillo FJ, Shi H, Burgos-Blasco B, Ly-Yang F, Donate-L\u00f3pez J, et al. Assessment of the anterior scleral thickness in central serous chorioretinopathy patients by optical coherence tomography. Jpn J Ophthalmol. 2021;65(6):769\u201378. https:\/\/doi.org\/10.1007\/s10384-021-00870-4.","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"867_CR70","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1111\/aos.16779","volume":"103","author":"P Forte","year":"2025","unstructured":"Forte P, Cattaneo J, Cardillo Piccolino F, Arrigo A, Corazza P, Musetti D, et al. Influence of scleral thickness on photodynamic therapy outcomes in central serous chorioretinopathy. Acta Ophthalmol. 2025;103(3):e165\u201375. https:\/\/doi.org\/10.1111\/aos.16779.","journal-title":"Acta Ophthalmol"},{"key":"867_CR71","unstructured":"European Medicines Agency. Reflection paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/reflection-paper-use-artificial-intelligence-ai-medicinal-product-lifecycle_en.pdf. Accessed 4 May 2026."}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-026-00867-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00867-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00867-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:14:09Z","timestamp":1785518049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-026-00867-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["867"],"URL":"https:\/\/doi.org\/10.1186\/s40942-026-00867-6","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article is based exclusively on previously published studies and does not involve human participants or animals performed by any of the authors.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"101"}}